Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

The new method improves accuracy in segmenting scalp tissue layers.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Timely zinc treatment is crucial for preventing severe complications in Acrodermatitis enteropathica.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

αCT1 improves scar appearance by changing early collagen structure.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Mice with autoimmune hair loss showed signs of heart problems.

Araliadiol protects skin cells from damage by boosting antioxidant defenses.

Combining shikimic acid and Prunus mume extract may effectively treat acne naturally.

Regenera Activa AMT effectively improves hair growth and reduces hair loss in androgenetic alopecia.